Patents by Inventor Young-Lan Hyun

Young-Lan Hyun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8053435
    Abstract: The present invention discloses novel naphthalenyloxypropenyl derivatives useful for inhibiting the enzyme activity of histone deacetylase, leading effective suppression of cancer cell proliferation.
    Type: Grant
    Filed: November 1, 2007
    Date of Patent: November 8, 2011
    Assignees: Korea Research Institute of Chemical Technology, Crystalgenomics, Inc.
    Inventors: Cheol Hae Lee, Hee Jung Jung, Jae Hak Kim, Won Jang Jeong, Joong Myung Cho, Seong Gu Ro, Young Lan Hyun, Cheol Soon Lee, Dongkyu Shin
  • Patent number: 7973060
    Abstract: A compound which is effective for inhibiting Fab I, and a method for treating a bacterial infection.
    Type: Grant
    Filed: October 11, 2006
    Date of Patent: July 5, 2011
    Assignee: CrystalGenomics, Inc.
    Inventors: Cheol Min Kim, Dong Gyu Shin, Seonggu Ro, Joong Myung Cho, Young Lan Hyun
  • Publication number: 20100069630
    Abstract: The present invention discloses novel naphthalenyloxypropenyl derivatives useful for inhibiting the enzyme activity of histone deacetylase, leading effective suppression of cancer cell proliferation.
    Type: Application
    Filed: November 1, 2007
    Publication date: March 18, 2010
    Applicants: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY, CRYSTALGENOMICS, INC
    Inventors: Cheol Hae Lee, Hee Jung Jung, Jae Hak Kim, Won Jang Jeong, Joong Myung Cho, Seong Gu Ro, Young Lan Hyun, Cheol Soon Lee
  • Publication number: 20090170847
    Abstract: The inventive imidazopyridine derivative can be used in a pharmaceutical composition for preventing or treating diseases such as diabetes, obesity, dementia, cancer, and inflammation, since it can efficiently inhibit the activities of several protein kinases including glycogen synthase kinase-3 (GSK-3), aurora kinase, extracellular signal-regulated kinase (ERK), protein kinase B (AKT), and the likes, to control signal transductions thereof.
    Type: Application
    Filed: January 23, 2007
    Publication date: July 2, 2009
    Inventors: Seung Chul Lee, Jin Seok Choi, Jung Hoon Oh, Boonsaeng Park, Yong Eun Kim, Jun Hee Lee, Dongkyu Shin, Cheol Min Kim, Young-Lan Hyun, Cheol Soon Lee, Joong-Myung Cho, Seonggu Ro
  • Publication number: 20070254882
    Abstract: The present invention relates to a novel sulfamide derivative, a pharmaceutically acceptable salt thereof and a pharmaceutical composition for upregulation of lipid metabolism comprising same as an active ingredient.
    Type: Application
    Filed: July 14, 2005
    Publication date: November 1, 2007
    Applicants: CRYSTAL GENOMICS, INC., KOREA RESEARCH INSTITUTE OF CHEMICAL
    Inventors: Joong Cho, Tae Lee, Seonggu Ro, Jin Kim, Young Jeon, Dong Shin, Young-Lan Hyun, Gyu Yon, Young-Gwi Yoon, Eun Choi, Hyeon Lee, Chwang Pak
  • Patent number: 7179832
    Abstract: Novel compounds having hydroxybenzoimidazole carboxylic amide are useful for inhibiting glycogen synthase kinase 3?(GSK-3?).
    Type: Grant
    Filed: January 20, 2004
    Date of Patent: February 20, 2007
    Assignees: Crystalgenomics, Inc., Yuyu Inc.
    Inventors: Joong Myung Cho, Seonggu Ro, Tae Gyu Lee, Kyung Joo Lee, Dongkyu Shin, Young-Lan Hyun, Seung Chul Lee, Jin Hwan Kim, Young Ho Jeon
  • Publication number: 20060079521
    Abstract: Novel compounds having hydroxybenzoimidazole carboxylic amide are useful for inhibiting glycogen synthase kinase 3? (GSK-3?).
    Type: Application
    Filed: January 20, 2004
    Publication date: April 13, 2006
    Inventors: Joong Cho, Seonggu Ro, Tae Lee, Kyung Lee, Dongkyu Shin, Young-Lan Hyun, Seung Lee, Jin Kim, Young Jeon